Updates on the NYSCF Community’s Fight Against COVID-19
We are proud of our scientists and Innovator community who are hard at work developing solutions for those impacted by COVID-19. This ranges from better detecting...
News
The latest news and updates about NYSCF and our collaborators
360 Results
Clear Filters
Ed Boyden Awarded Wilhelm Exner Medal
NYSCF – Robertson Neuroscience Investigator Alumnus and Y. Eva Tan Professor in Neurotechnology at MIT Ed Boyden, PhD, will receive the prestigious 2020 Wilhelm Exner Medal...
A Message to the NYSCF Community from Susan L. Solomon
On behalf of all of us at The NYSCF Research Institute, I am writing to express our hope and best wishes for you and your loved...
We Need 100% of the Available Brainpower to Reach Cures. NYSCF’s Initiative on Women in Science and Engineering Is Fighting to Make Sure We Get There.
“We were determined to do something more than just write another white paper that would end up in a drawer,” explained NYSCF Associate Vice President of...
Progress, Challenges, and Promise: On the Road to a Type 1 Diabetes Cure
“How many people were promised a cure [for type 1 diabetes] within five or ten years?” JDRF CEO Aaron Kowalski asks the audience. Half the hands...
NYSCF Scientists Talk Space, Stem Cells, and their Pioneering Study of MS and PD
The International Space Station (ISS) houses more than astronauts: the football-field-sized spacecraft is also home to a large range of research projects carried out in the...
New Hope for Alzheimer’s: Scientists and Clinicians Present Emerging Therapies for a Notoriously Challenging Disease
Alzheimer’s remains one of the most devastating diseases in the world, and though there are more than 44 million people with it worldwide, there are still...
A New Therapeutic Angle for ALS
The Context: Amyotrophic lateral sclerosis (ALS) affects motor neurons, the cells that send signals to our muscles, gradually paralyzing patients. Scientists know that a mutation in...
Roadmap of Brain Development Offers Insight into Autism and Schizophrenia
The Context: Studying brain development can be difficult since scientists cannot easily access developing brain tissue. Creating models of human brain development from stem cells allows...
Going Gray? Stress — and Depleted Stem Cells — Are the Likely Culprits
The Context: We’ve all heard that stress can turn your hair gray. But there hasn’t been much scientific evidence that this is true — and if...
Susan L. Solomon Receives 2020 ISSCR Award
We are delighted to share that NYSCF CEO Susan L. Solomon will receive the 2020 Public Service Award from the International Society for Stem Cell Research...
Building Bruch’s Membrane to Better Understand Macular Degeneration
The Context: Age-related macular degeneration (AMD) results from the death of retinal pigmented epithelial cells (RPEs) in the eye. Bruch’s membrane is a structure that sits...
CYTOVIA Therapeutics and the New York Stem Cell Foundation Research Institute Enter into a Partnership to Develop iPSC-Derived CAR NK Therapeutics
Research teams will use stem cell and gene editing technologies to advance NK cell-based therapies for cancer New York, New York (January 9, 2020) – The...
2019 in Review
As we enter 2020, we’re taking a moment to look back at the incredible advancements of 2019. From forming new precision medicine partnerships to sending multiple...
For a Family Affected by Rare Disease, Stem Cells are Providing New Hope
When Ariya Panwala was born, she was a happy, squirmy baby — but after a few months, her parents noticed she wasn’t advancing as expected. Her...
How ‘Remixing’ a Gene May Lead to Schizophrenia and other Neuropsychiatric Diseases
The Context: NRXN1 is a gene that is broadly implicated in neuropsychiatric disorders such as schizophrenia, autism spectrum disorder, and epilepsy; however, the ways in which...
From Casual to Compulsive: How Brain Circuitry Affects Alcohol Use
The Context: Alcohol use disorders affect roughly 15 million Americans, but why some people are more susceptible to compulsive drinking than others is not well understood....
What’s the Best Way to Preserve Personalized Bone Grafts?
The Context: After a bone graft is created from stem cells, it will likely have to be preserved for a while before it reaches a patient....
NYSCF Collaboration Sends Multiple Sclerosis and Parkinson’s Disease Brain Cells to Space
Brain cells derived from the stem cells of multiple sclerosis and Parkinson’s disease patients are on their way up to the International Space Station! This afternoon,...
NYSCF Partners with Alumnus Chris Gregg to Personalize Cancer Treatment with Big Data
Cancer patients can often feel powerless. They want to do all they can, but many feel as though they don’t have much control over their treatment....
First-in-kind Human 3-dimensional Models of Parkinson’s Disease and Progressive Multiple Sclerosis Launching to the International Space Station
First patient-derived, induced pluripotent stem cell disease-specific organoid models in microgravity to advance understanding of neurodegenerative disease LOUISVILLE, KY — (BUSINESS WIRE) — The National Stem...
Precision Medicine and the Power of Stem Cells: Highlights of the 2019 NYSCF Conference
In 2006, Shinya Yamanaka, MD, PhD, made a discovery that revolutionized biomedical research and earned him a Nobel Prize. His lab found that stem cells, the...
NYSCF, Johns Hopkins, and Bloomberg Philanthropies Partner to Advance Precision Medicine
A new collaboration between the NYSCF Research Institute, Johns Hopkins University School of Medicine (JHUSOM), and Bloomberg Philanthropies is aiming to push precision medicine forward using...
NYSCF Announces 2019 Class of NYSCF – Robertson Investigators
New York, NY (October 22, 2019) – The New York Stem Cell Foundation (NYSCF) today announced the 2019 class of NYSCF – Robertson Investigators, welcoming six...
New Hope for a Rare and Deadly Neurological Disease
The Context: Pelizaeus – Merzbacher disease (PMD) is a rare neurological condition typically diagnosed in infancy which often becomes fatal by a patient’s teenage years. While...